Effect of Postmortem Delay on Imidazoline Receptor-Binding Proteins in Human and Mouse Brain

Annals of the New York Academy of Sciences

Volumn 1009, Issue , 2003, Pages 341-346

  Ma, John K ^a   Zhu, He ^a   Piletz, John E ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b Jackson State University   (United States)

Author keywords

Antiserum; Imidazoline receptor; IRAS; Postmortem

Indexed keywords

BINDING PROTEIN; IMIDAZOLINE RECEPTOR;

ANIMAL TISSUE; BINDING SITE; BRAIN TISSUE; CADAVER; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; HUMAN; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PROTEIN BINDING; SUICIDE; TISSUE CULTURE; VICTIM;

ANIMALIA;

EID: 1342347773     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1304.043     Document Type: Conference Paper

References (14)

1. BOUSQUET, P., J. FELDMAN & J. SCHWARTZ. 1984. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230: 232-236.
2. MANJI, H.K., M.V. RUDORFER & W.Z. POTTER. 1994. Affective disorders and adrenergic function. In Adrenergic Dysfunction and Psychobiology. O.G. Cameron, Ed.: 365-401. American Psychiatric Press Inc. Washington, DC.
3. ZHU, H., I.A. PAUL, D.E. STEC, et al. 2003. Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses. Brain Res. 964: 9-20.
4. TESSON, F., I. LIMON-BOULEZ, P. URBAN, et al. 1995. Localization of I2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270: 9856-9861.
5. WANG, H., S. REGUNATHAN, M.P. MEELEY, et al. 1992. Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. Mol. Pharmacol. 42: 792-801.
6. ERNSBERGER, P., M.E. GRAVES, L.M. GRAFF, et al. 1995. I1-Imidazoline receptors: definition, characterization, distribution and transmembrane signalling. Ann. N. Y. Acad. Sci. 763: 22-42.
7. WANG, H., S. REGUNATHAN, D.A. RUGGIERO, et al. 1993. Production and characterization of antibodies specific for the imidazoline receptor protein. Mol. Pharmacol. 43: 509-515.
8. PILETZ, J.E., T.R. IVANOV, J.D. SHARP, et al. 2000. Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol. 19: 319-329.
9. IVANOV, T.R., H. ZHU, S. REGUNATHAN, et al. 1998. Co-detection by two imidazoline receptor protein antisera of a novel 85 kilodalton protein. Biochem. Pharmacol. 55: 649-655.
10. ESCRIBA, P.V., A. OZAITA & J.A. GARCIA-SEVILLA. 1999. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods. Ann. N. Y. Acad. Sci. 881: 8-25.
11. GARCIA-SEVILLA, J.A., P.V. ESCRIBA, M. SASTRE, et al. 1996. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch. Gen. Psychiatry 53: 803-810.
12. PILETZ, J.E., H. ZHU, G. ORDWAY, et al. 2000. Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression. Biol. Psychiatry 48: 910-919.
13. PILETZ, I.E., J.C. JONES, H. ZHU, et al. 1999. Imidazoline receptor antisera-selected cDNA clone and mRNA distribution. Ann. N. Y. Acad Sci. 881: 1-7.
14. IVANOV, T.R., Y. FENG, H. WANG, et al. 1998. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists. J. Psychiatr. Res. 32: 65-79.